New stock news | Alibaba (09988) plans to spin off its AI chip enterprise "Pingtouge" for independent listing.
According to media reports citing informed sources, Alibaba (09988) is preparing to push forward its AI chip manufacturing company "Pingtou Ge" (T-Head) to list independently.
According to reports citing informed sources, Alibaba (09988) is preparing to push its AI chip manufacturing company "T-Head" to go public independently. Alibaba plans to restructure it as a business entity partially owned by employees and then seek an initial public offering (IPO), but the specific listing time has not yet been determined, and the action is still in the preparation stage.
Public information shows that T-Head Semiconductor Co., Ltd. was established in September 2018 as the main body of Alibaba Group's wholly-owned semiconductor chip business, with a full-stack product series (covering data center chips, IoT chips, etc.), realizing end-to-end coverage of the chip design chain.
So far, T-Head has launched AI inference chips Haiguang 800, CPU Yitian 710, and AI chip PPU in the field of computing chips, and SSD controller chip Zhenyue 510 in the field of storage chips. It is said to also launch related chips in the field of network chips, and has laid out a full-stack chip for data centers. T-Head has also launched the YuZhen IoT chip in the edge chip sector, with hundreds of millions in shipments, covering cloud and end terminals.
Before this, in addition to Alibaba, another internet giant BIDU-SW (09888) also announced a plan to split off Kunlun Core. According to its announcement, on January 1, 2026, Kunlun Core submitted an application form (Form A1) to the Hong Kong Stock Exchange through its joint sponsors in a confidential manner to apply for the approval of Kunlun Core's shares to be listed and traded on the main board of the Hong Kong Stock Exchange. After the split, Kunlun Core will remain a subsidiary of Baidu.
Related Articles

YUEXIUTRANSPORT (01052) obtains a revolving loan financing of 450 million RMB.

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer
YUEXIUTRANSPORT (01052) obtains a revolving loan financing of 450 million RMB.

ZHONGZHIPHARM(03737) issues a profit warning, expecting a decrease in annual net profit of no less than 70%.

SUNHO BIO-B(02898): Jiang Xiaoling appointed as Chief Executive Officer and Chief Scientific Officer

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


